E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/6/2013 in the Prospect News Bank Loan Daily and Prospect News High Yield Daily.

S&P: Endo on negative watch

Standard & Poor's said it affirmed the BB- corporate credit rating on Endo Health Solutions Inc.

S&P also said it placed the BB+ rating on Endo's senior secured debt and BB- rating on Endo's senior unsecured debt on CreditWatch with negative implications because the size of these debt classes could increase relative to the estimate of Endo's value in the event of default.

The recovery rating on the senior secured debt is 1, indicating 90% to 100% expected default recovery, the agency said, and the recovery rating on the senior unsecured debt is 4, indicating 30% to 50% expected default recovery.

The outlook is stable.

The acquisition of Paladin does not alter the fair assessment of Endo's business risk profile with gradually improving product diversity, S&P said.

The agency said it does not expect the transactions to materially affect Endo's leverage. But, S&P said it continues to believe Endo's growth goals and financial policies are aggressive and leverage is expected to rise to more than 4x from 2.7x as of Sept. 30, reflecting both higher debt levels and lower EBITDA.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.